BG
EDIT icon

BlackRock Group’s Editas Medicine EDIT Stock Holding History

BlackRock Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$189K Buy
11,650
+2,973
+34% +$45.1K ﹤0.01% 2668
2016
Q3 		$117K Buy
+8,677
New +$178K ﹤0.01% 2788

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock Group's EDIT Position: Q4 2016 in Review

BlackRock Group increased its Editas Medicine (EDIT) stake by 34% in Q4 2016, buying an estimated $45.1K and bringing the position to 11,650 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #2668.

BlackRock Group first reported a position in EDIT in Q3 2016 and has held it in 2 quarters since. 84 funds tracked by Wall St. Rank hold EDIT as of Q4 2016.

  • BlackRock Group held 11,650 shares of Editas Medicine worth $189K as of Q4 2016.
  • BlackRock Group bought 2,973 Editas Medicine shares in Q4 2016, an estimated $45.1K.
  • Editas Medicine made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2668 holding.
  • BlackRock Group first reported a position in Editas Medicine in Q3 2016 and has held it in 2 quarters since.
  • 84 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.